Clinical Trial Update: Trial of Quercetin in the Treatment and Prevention of Chemotherapy-induced Neuropathic Pain in Cancer Patients [EARLY_Phase 1]

View source ↗

Summary

An early-phase trial investigating quercetin for chemotherapy-induced peripheral neuropathy in cancer patients has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Peripheral Neuropathy
• Polyneuropathy

Drugs mentioned

• Quercetin (quercetin)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Polyneuropathies and Other Disorders of the Peripheral Nervous System, Chemotherapy Induced Neuropathic Pain | EARLY_Phase 1 | Status: WITHDRAWN